Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b
Abstract Objective: To determine the effect of IV methylprednisolone (IVMP) on brain fraction volum...
Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis
Abstract We conducted an open-label pilot clinical trial to evaluate the safety and efficacy of addi...
Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study
Abstract Magnetic resonance imaging (MRI) has been used to study the history of multiple sclerosis (...
Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients
Abstract Objective: To determine the effect of interferon-beta-1b (IFNbeta-1b) treatment on total c...
A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients
Abstract The purpose of this open-label, crossover study was to determine the safety and efficacy of...
MRI as a marker for disease heterogeneity in multiple sclerosis
Abstract Background: Whereas recent data from imaging studies challenge the prevailing notion that ...
MRI of silicone vitreous ocular implants with phantom correlation
Abstract We imaged two patients who had silicone oil injected their vitreous cavities. The images de...
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis
Abstract CD95/CD95 ligand interactions are critically involved in the negative regulation of periphe...
Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure
Abstract MRI is a valuable tool to examine the pathophysiology and natural history of multiple scler...
Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis
Abstract Objective: To investigate the temporal relationship between inflammation and cerebral atro...